These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 36227594)
1. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN; JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN; JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 infections post-vaccination by HIV status in the United States. Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon K; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg M; Skarbinski J; Leyden WA; Williams CF; Althoff KN; medRxiv; 2021 Dec; ():. PubMed ID: 34909791 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Breakthrough Infection after Vaccination and Substance Use Disorders: A Longitudinal Cohort of People with and without HIV Receiving Care in the United States Veterans Health Administration. Soyer EM; McGinnis KA; Justice AC; Hsieh E; Rodriguez-Barradas MC; Williams EC; Park LS AIDS Behav; 2024 Nov; 28(11):3605-3614. PubMed ID: 39046612 [TBL] [Abstract][Full Text] [Related]
5. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout. Lea AN; Leyden WA; Sofrygin O; Marafino BJ; Skarbinski J; Napravnik S; Agil D; Augenbraun M; Benning L; Horberg MA; Jefferson C; Marconi VC; Park LS; Gordon KS; Bastarache L; Gangireddy S; Althoff KN; Coburn SB; Gebo KA; Lang R; Williams C; Silverberg MJ Clin Infect Dis; 2023 May; 76(10):1727-1734. PubMed ID: 36861341 [TBL] [Abstract][Full Text] [Related]
6. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US. Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC; JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505 [TBL] [Abstract][Full Text] [Related]
7. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 Breakthrough Infections Among People With HIV: A Statewide Cohort Analysis. Yang X; Zhang J; Chen S; Liu Z; Poland GA; Olatosi B; Weissman S; Li X J Acquir Immune Defic Syndr; 2024 Oct; 97(2):107-116. PubMed ID: 39250644 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts. Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN; J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV. Hechter RC; Qian L; Liu IA; Sy LS; Ryan DS; Xu S; Williams JTB; Klein NP; Kaiser RM; Liles EG; Glanz JM; Jackson LA; Sundaram ME; Weintraub ES; Tseng HF JAMA Netw Open; 2024 Jun; 7(6):e2415220. PubMed ID: 38842808 [TBL] [Abstract][Full Text] [Related]
11. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer. Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. Möller IK; Gisslén M; Wagner P; Sparén P; Carlander C HIV Med; 2023 Oct; 24(10):1045-1055. PubMed ID: 37286199 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 breakthrough infections among people living with and without HIV: A statewide cohort analysis. Yang X; Zhang J; Liu Z; Chen S; Olatosi B; Poland GA; Weissman S; Li X Int J Infect Dis; 2024 Feb; 139():21-27. PubMed ID: 38013151 [TBL] [Abstract][Full Text] [Related]
14. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951 [TBL] [Abstract][Full Text] [Related]
15. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals. Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571 [TBL] [Abstract][Full Text] [Related]
16. Influenza Vaccination Uptake and Associated Factors Among Adults With and Without Human Immunodeficiency Virus in a Large, Integrated Healthcare System. Imp BM; Levine T; Satre DD; Skarbinski J; Luu MN; Sterling SA; Silverberg MJ Clin Infect Dis; 2023 Jul; 77(1):56-63. PubMed ID: 36857440 [TBL] [Abstract][Full Text] [Related]
17. Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. Theodore DA; Branche AR; Zhang L; Graciaa DS; Choudhary M; Hatlen TJ; Osman R; Babu TM; Robinson ST; Gilbert PB; Follmann D; Janes H; Kublin JG; Baden LR; Goepfert P; Gray GE; Grinsztejn B; Kotloff KL; Gay CL; Leav B; Miller J; Hirsch I; Sadoff J; Dunkle LM; Neuzil KM; Corey L; Falsey AR; El Sahly HM; Sobieszczyk ME; Huang Y; JAMA Netw Open; 2023 Jul; 6(7):e2323349. PubMed ID: 37440227 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022. Teran RA; Gagner A; Gretsch S; Lauritsen J; Galanto D; Walblay K; Ruestow P; Korban C; Pacilli M; Kern D; Black SR; Tabidze I Emerg Infect Dis; 2023 Nov; 29(11):2257-2265. PubMed ID: 37877555 [TBL] [Abstract][Full Text] [Related]
19. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021. Wang W; Kaelber DC; Xu R; Berger NA JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485 [TBL] [Abstract][Full Text] [Related]
20. Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2. Opsteen S; Fram T; Files JK; Levitan EB; Goepfert P; Erdmann N J Acquir Immune Defic Syndr; 2024 May; 96(1):92-100. PubMed ID: 38408318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]